Type / Class
Equity / Common Stock, par value $.0001 per share
Shares outstanding
6.84M
Number of holders
53
Total 13F shares, excl. options
47.8M
Shares change
-6.66M
Total reported value, excl. options
$33.5M
Value change
-$6.82M
Put/Call ratio
0.01
Number of buys
16
Number of sells
-41
Price
$0.70

Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q3 2024

77 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q3 2024.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47.8M shares .
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (22.7M shares), FMR LLC (7.07M shares), 5AM Venture Management, LLC (6.36M shares), Hudson Bay Capital Management LP (2.47M shares), VANGUARD GROUP INC (1.95M shares), COWEN AND COMPANY, LLC (1.22M shares), JOHNSON & JOHNSON (1.07M shares), RENAISSANCE TECHNOLOGIES LLC (756K shares), Sarissa Capital Management LP (618K shares), and BlackRock, Inc. (488K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.